1) Medical lasers: Ho:YAG can be competed away, not trivially "replaced"
Substitute path A: Thulium fiber laser (TFL)
In urology (stone lithotripsy, and increasingly prostate work), TFL has become the most credible competitor to Ho:YAG. Comparative studies and meta-analyses generally frame TFL as at least comparable, with potential efficiency advantages in some settings, while noting that outcomes depend heavily on settings and technique.
What changes if a clinic shifts Ho:YAG → TFL:
- Different consoles and fibers
- Different parameter "sweet spots"
- Training and preference cycles (slow-moving, but real)
Substitute path B: Pulsed thulium:YAG (p-Tm:YAG) in select workflows
Clinical and technical comparisons also treat pulsed thulium:YAG as a competitor that can outperform Ho:YAG on certain efficiency metrics, depending on settings and target outcomes.
Substitute path C: Redesign the procedure, not just the laser
Some "substitution" is changing technique (dusting vs fragmentation, basket use, anti-retropulsion strategy) to reduce the need for a specific laser performance envelope. That doesn't eliminate Ho demand, but it reduces the "Ho is mandatory" mindset.
Bottom line: Ho:YAG is still a reference platform in many places, but TFL and p-Tm:YAG are real substitution pressure, not a theoretical idea.